Osborn Williams & Donohoe’s Exact Sciences EXAS Stock Holding History

Osborn Williams & Donohoe’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-60	Closed	-$6K	–	419
2019 Q1	$6K	Buy	+60	New	+$5.11K	﹤0.01%	665

Other funds holding EXAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Osborn Williams & Donohoe's EXAS Position: Q2 2019 in Review

Osborn Williams & Donohoe sold out of Exact Sciences (EXAS) in Q2 2019, closing a stake of 60 shares — an estimated $6K sold.

Osborn Williams & Donohoe first reported a position in EXAS in Q1 2019 and held it in 1 quarter. The position peaked at $6K in Q1 2019. 472 funds tracked by Wall St. Rank hold EXAS as of Q2 2019.

Osborn Williams & Donohoe reported no remaining Exact Sciences position as of Q2 2019 after selling out during the quarter.
Osborn Williams & Donohoe sold 60 Exact Sciences shares in Q2 2019, an estimated $6K.
Osborn Williams & Donohoe first reported a position in Exact Sciences in Q1 2019 and held it in 1 quarter.
Osborn Williams & Donohoe's Exact Sciences position peaked at $6K in Q1 2019.
472 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2019.

Based on Osborn Williams & Donohoe's 13F filing for Q2 2019, filed 26 Jul 2019.